Volume 23, Number 10—October 2017
Dispatch
Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008–2015
Takaaki Tanaka, Tomohiro Oishi
, Ippei Miyata, Shoko Wakabayashi, Mina Kono, Sahoko Ono, Atsushi Kato, Yoko Fukuda, Aki Saito, Eisuke Kondo, Hideto Teranishi, Yuhei Tanaka, Tokio Wakabayashi, Hiroto Akaike, Satoko Ogita, Naoki Ohno, Takashi Nakano, Kihei Terada, and Kazunobu Ouchi
, Ippei Miyata, Shoko Wakabayashi, Mina Kono, Sahoko Ono, Atsushi Kato, Yoko Fukuda, Aki Saito, Eisuke Kondo, Hideto Teranishi, Yuhei Tanaka, Tokio Wakabayashi, Hiroto Akaike, Satoko Ogita, Naoki Ohno, Takashi Nakano, Kihei Terada, and Kazunobu Ouchi
Table 1
Mycoplasma pneumoniae infections diagnosed by real-time PCR and prevalence of macrolide-resistant M. pneumoniae, by district, Japan
| District |
Average age, y (range) |
No. patients (M:F) |
Macrolide resistance, % (no. positive/total no. patients)* | |||
|---|---|---|---|---|---|---|
| 2008–2010 |
2011–2012 |
2013–2015 |
Total |
|||
| Kyushu | 6.4 (0–14) | 239 (1.2:1) | – | 64.1 (82/128) | 27.9 (31/111) | 47.3 (113/239) |
| Chugoku-Shikoku | 7.3 (0–15) | 623 (1.4:1) | 68.6 (59/86) | 70.6 (339/480) | 80.7 (46/57) | 71.3 (444/623) |
| Kinki | 7.1 (1–15) | 227 (1:1) | 33.3 (7/21) | 86.1 (162/188) | 66.7 (12/18) | 79.7 (181/227) |
| Kanto-Chubu | 7.5 (0–13) | 268 (1.1:1) | – | 80.1 (197/246) | 72.7 (16/22) | 79.5 (213/268) |
| Hokkaido-Tohoku |
7.7 (0–13) |
91 (1.2:1) |
84.2 (32/38) |
68.1 (32/47) |
16.7 (1/6) |
71.4 (65/91) |
| Total | 7.3 (0–15) | 1,448 (1.3:1) | 67.6 (98/145) | 74.6 (812/1,089) | 49.5 (106/214) | 70.2 (1,016/1,448) |
*2008–2010, prepandemic; 2011–2012, pandemic; 2013–2015, post pandemic.
No table matches the in-text citation "Table 1". Please supply the missing table or delete the citation.
Page created: September 18, 2017
Page updated: September 18, 2017
Page reviewed: September 18, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.